Gautam George
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gautam George has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ross Summer
Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Sidney Kimmel Medical Collegeat, Thomas Jefferson University , Philadelphia, PA, USA
6 shared publications - Jesse Roman
The Jane and Leonard Korman Respiratory Institute Thomas Jefferson University Philadelphia, Pennsylvania
3 shared publications - Baskaran Sundaram
Radiology, Thomas Jefferson University Hospitals, Philadelphia, PA, United States
2 shared publications - Daniel Richard Kramer
University of Colorado Anschutz Medical Campus
2 shared publications J. Fares
Thomas Jefferson University Hospitals, Philadelphia, PA, United States
2 shared publications- Joy Zhao
Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA
2 shared publications
Latest Publications
- Open Access
- 3 August 2023
- Published by Wiley in Respirology
- Vol. 28 (11) , 1036-1042
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis
Background and Objective: Racial disparities have been documented in care of many respiratory diseases but little is known about the impact of race on the treatment of interstitial lung diseases. The purpose of this study was to determine how race and ethnicity influence treatment of idiopathic pulmonary fibrosis.Methods: Adults with idiopathic pulmonary fibrosis (>18 years) were identified using TriNetX database and paired‐wised comparisons were performed for antifibrotic treatment among White, Black, Hispanic and Asian patients. Mortality of treated and untreated IPF patients was compared after propensity score matching for age, sex, nicotine dependence, oxygen dependence and predicted FVC. Additional comparisons were performed in subgroups of IPF patients older than 65 years of age and with lower lung function.Results: Of 47,184 IPF patients identified, the majority were White (35,082), followed by Hispanic (6079), Black (5245) and Asian (1221). When subgroups were submitted to matched cohort pair‐wise comparisons, anti‐fibrotic usage was lower among Black patients compared to White (6.2% vs. 11.4%, p‐value p‐value p‐value = 0.0006). Similar treatment differences were noted in Black individuals older than 65 years and those with lower lung function. Mortality among White patients, but not Hispanic, Black, or Asian patients, was lower in patients on antifibrotic therapy versus not on therapy.Conclusion: This study demonstrated that Black IPF patients had lower antifibrotic use compared to White, Hispanic and Asian patients. Our findings suggest that urgent action is needed to understand the reason why racial disparities exist in the treatment of IPF.
- 3 August 2023
- Published by Wiley in Respirology
- Vol. 28 (11) , 1036-1042
Open AccessRacial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis
Background and Objective: Racial disparities have been documented in care of many respiratory diseases but little is known about the impact of race on the treatment of interstitial lung diseases. The purpose of this study was to determine how race and ethnicity influence treatment of idiopathic pulmonary fibrosis.Methods: Adults with idiopathic pulmonary fibrosis (>18 years) were identified using TriNetX database and paired‐wised comparisons were performed for antifibrotic treatment among White, Black, Hispanic and Asian patients. Mortality of treated and untreated IPF patients was compared after propensity score matching for age, sex, nicotine dependence, oxygen dependence and predicted FVC. Additional comparisons were performed in subgroups of IPF patients older than 65 years of age and with lower lung function.Results: Of 47,184 IPF patients identified, the majority were White (35,082), followed by Hispanic (6079), Black (5245) and Asian (1221). When subgroups were submitted to matched cohort pair‐wise comparisons, anti‐fibrotic usage was lower among Black patients compared to White (6.2% vs. 11.4%, p‐value p‐value p‐value = 0.0006). Similar treatment differences were noted in Black individuals older than 65 years and those with lower lung function. Mortality among White patients, but not Hispanic, Black, or Asian patients, was lower in patients on antifibrotic therapy versus not on therapy.Conclusion: This study demonstrated that Black IPF patients had lower antifibrotic use compared to White, Hispanic and Asian patients. Our findings suggest that urgent action is needed to understand the reason why racial disparities exist in the treatment of IPF.
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A5943
Racial and Ethnic Disparities in Antifibrotic Therapy in Idiopathic Pulmonary Fibrosis
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A5943
Racial and Ethnic Disparities in Antifibrotic Therapy in Idiopathic Pulmonary Fibrosis
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A6228
Serum Ace Levels and RAAS Modulation on Mortality in Patients With Sarcoidosis
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A6228
Serum Ace Levels and RAAS Modulation on Mortality in Patients With Sarcoidosis
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A4984
Bilateral Bronchoalveolar Lavage in the Workup of Interstitial Lung Disease
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A4984
Bilateral Bronchoalveolar Lavage in the Workup of Interstitial Lung Disease
- Open Access
- 7 March 2023
- Published by Elsevier in EBioMedicine
- Vol. 90, 104513
Moving senolytics closer to the clinic in IPF
- 7 March 2023
- Published by Elsevier in EBioMedicine
- Vol. 90, 104513
Open AccessMoving senolytics closer to the clinic in IPF
- Open Access
- 1 August 2022
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 19 (8) , 1435-1437
Mortality among Patients with COVID-19 and Different Interstitial Lung Disease Subtypes: A Multicenter Cohort Study
- 1 August 2022
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 19 (8) , 1435-1437
Open AccessMortality among Patients with COVID-19 and Different Interstitial Lung Disease Subtypes: A Multicenter Cohort Study